At a glance
- Originator Abbott Laboratories
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Rheumatic disorders